{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T09:31:13Z","timestamp":1789637473622,"version":"4.0.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T00:00:00Z","timestamp":1653609600000},"content-version":"vor","delay-in-days":1517,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100009601","name":"Beijing Municipal Administration of Hospitals","doi-asserted-by":"publisher","award":["XMLX201710"],"award-info":[{"award-number":["XMLX201710"]}],"id":[{"id":"10.13039\/501100009601","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstert.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.fertnstert.2017.12.023","type":"journal-article","created":{"date-parts":[[2018,3,7]],"date-time":"2018-03-07T23:54:43Z","timestamp":1520466883000},"page":"720-727","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["Comparing the risk of adverse pregnancy outcomes of Chinese patients with polycystic ovary syndrome with and without antiandrogenic pretreatment"],"prefix":"10.1016","volume":"109","author":[{"given":"Yanglu","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyan","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Husheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guiju","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfred O.","family":"Mueck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2017.12.023_bib1","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/humrep\/der396","article-title":"Consensus on women's health aspects of polycystic ovary syndrome (PCOS)","volume":"27","year":"2012","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2017.12.023_bib2","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.mcna.2014.09.003","article-title":"Polycystic ovarian syndrome","volume":"99","author":"Trikudanathan","year":"2015","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.fertnstert.2017.12.023_bib3","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.fertnstert.2011.09.024","article-title":"Consensus on women\u2019s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE\/ASRM-Sponsored 3rd PCOS Consensus Workshop Group","volume":"97","author":"Fauser","year":"2012","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2017.12.023_bib4","doi-asserted-by":"crossref","first-page":"736","DOI":"10.3109\/09513590.2010.481025","article-title":"Atherogenic metabolic profile in PCOS patients: role of obesity and hyperandrogenism","volume":"26","author":"Castelo-Branco","year":"2010","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.fertnstert.2017.12.023_bib5","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nrendo.2010.217","article-title":"Polycystic ovary syndrome: etiology, pathogenesis and diagnosis","volume":"7","author":"Goodarzi","year":"2011","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.fertnstert.2017.12.023_bib6","first-page":"1626","article-title":"Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome: a multicenter, double blind, placebo-controlled trial","volume":"86","author":"Azziz","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2017.12.023_bib7","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1093\/humrep\/dem426","article-title":"Consensus on infertility treatment related to polycystic ovary syndrome","volume":"23","year":"2008","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2017.12.023_bib8","doi-asserted-by":"crossref","first-page":"5787104","DOI":"10.1155\/2016\/5787104","article-title":"Risk for gestational diabetes mellitus and adverse birth outcomes in Chinese women with polycystic ovary syndrome","volume":"2016","author":"Xiao","year":"2016","journal-title":"Int J Endocrinol"},{"key":"10.1016\/j.fertnstert.2017.12.023_bib9","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1477-7827-11-56","article-title":"Obstetric complications in women with polycystic ovary syndrome: a systematic review and meta-analysis","volume":"11","author":"Qin","year":"2013","journal-title":"Reprod Biol Endocrinol"},{"key":"10.1016\/j.fertnstert.2017.12.023_bib10","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.mce.2012.07.011","article-title":"Disordered follicle development","volume":"373","author":"Chang","year":"2013","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.fertnstert.2017.12.023_bib11","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/humupd\/dmq032","article-title":"Extra- and intra-ovarian factors in polycystic ovary syndrome: impact on oocyte maturation and embryo developmental competence","volume":"17","author":"Qiao","year":"2011","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2017.12.023_bib12","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1177\/1933719114561552","article-title":"Obesity and PCOS: the effect of metabolic derangements on endometrial receptivity at the time of implantation","volume":"22","author":"Schulte","year":"2015","journal-title":"Reprod Sci"},{"key":"10.1016\/j.fertnstert.2017.12.023_bib13","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/1471-0528.12558","article-title":"Increased risk of preterm delivery and pre-eclampsia in women with polycystic ovary syndrome and hyperandrogenaemia","volume":"121","author":"Naver","year":"2014","journal-title":"Br J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2017.12.023_bib14","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ogc.2014.09.003","article-title":"Endocrine and reproductive effects of polycystic ovarian syndrome","volume":"42","author":"Ecklund","year":"2015","journal-title":"Obstet Gynecol Clin North Am"},{"key":"10.1016\/j.fertnstert.2017.12.023_bib15","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1055\/s-2007-992931","article-title":"Oral contraceptives in polycystic ovary syndrome: risk-benefit assessment","volume":"26","author":"Yildiz","year":"2008","journal-title":"Semin Reprod Med"},{"key":"10.1016\/j.fertnstert.2017.12.023_bib16","doi-asserted-by":"crossref","first-page":"332","DOI":"10.3109\/09513590.2014.995621","article-title":"Successive and cyclic oral contraceptive pill pretreatment improves IVF\/ICSI outcomes of PCOS patients and ameliorates hyperandrogenism and antral follicle excess","volume":"31","author":"Pan","year":"2015","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.fertnstert.2017.12.023_bib17","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1016\/j.fertnstert.2007.05.035","article-title":"Pretreatment with oral contraceptives in infertile anovulatory patients with polycystic ovary syndrome who receive gonadotropins for controlled ovarian stimulation","volume":"89","author":"Palomba","year":"2008","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2017.12.023_bib18","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/humrep\/deh098","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)","volume":"19","year":"2004","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2017.12.023_bib19","doi-asserted-by":"crossref","first-page":"676","DOI":"10.2337\/dc10-0719","article-title":"International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy","volume":"33","author":"Metzger","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.fertnstert.2017.12.023_bib20","first-page":"1017","article-title":"Pregnancy complications and glucose intolerance in women with polycystic ovary syndrome","volume":"62","author":"Sawada","year":"2015","journal-title":"Endocrinol J"},{"key":"10.1016\/j.fertnstert.2017.12.023_bib21","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3109\/09513590.2015.1101438","article-title":"The effects of polycystic ovary syndrome on gestational diabetes mellitus","volume":"32","author":"Aktun","year":"2016","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.fertnstert.2017.12.023_bib22","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/s12887-017-0901-1","article-title":"Low birth weight and macrosomia in Tigray, Northern Ethiopia: who are the mothers at risk?","volume":"17","author":"Mengesha","year":"2017","journal-title":"BMC Pediatr"},{"key":"10.1016\/j.fertnstert.2017.12.023_bib23","doi-asserted-by":"crossref","first-page":"182582","DOI":"10.1155\/2013\/182582","article-title":"Risks for gestational diabetes mellitus and pregnancy-induced hypertension are increased in polycystic ovary syndrome","volume":"2013","author":"Wang","year":"2013","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.fertnstert.2017.12.023_bib24","doi-asserted-by":"crossref","first-page":"e4863","DOI":"10.1097\/MD.0000000000004863","article-title":"Association between polycystic ovary syndrome and the risk of pregnancy complications: A PRISMA-compliant systematic review and meta-analysis","volume":"95","author":"Yu","year":"2016","journal-title":"Medicine"},{"key":"10.1016\/j.fertnstert.2017.12.023_bib25","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/ijgo.12205","article-title":"Prevalence of gestational diabetes mellitus evaluated by universal screening with a 75-g, 2-hour oral glucose tolerance test and IADPSG criteria","volume":"138","author":"Karcaaltincaba","year":"2017","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.fertnstert.2017.12.023_bib26","doi-asserted-by":"crossref","first-page":"523","DOI":"10.7196\/SAMJ.2017.v107i6.12043","article-title":"Screening for gestational diabetes mellitus in a South African population: prevalence, comparison of diagnostic criteria and the role of risk factors","volume":"107","author":"Adam","year":"2017","journal-title":"S Afr Med J"},{"key":"10.1016\/j.fertnstert.2017.12.023_bib27","series-title":"Diabetes in pregnancy: management of diabetes and its complications from preconception to the postnatal period","year":"2015"},{"key":"10.1016\/j.fertnstert.2017.12.023_bib28","doi-asserted-by":"crossref","first-page":"61048","DOI":"10.18632\/oncotarget.17824","article-title":"Quantitative assessment of the effect of pre-gestational diabetes and risk of adverse maternal, perinatal and neonatal outcomes","volume":"8","author":"Yu","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.fertnstert.2017.12.023_bib29","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.mce.2012.10.029","article-title":"Longterm management of polycystic ovarian syndrome (PCOS)","volume":"373","author":"Bates","year":"2013","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.fertnstert.2017.12.023_bib30","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1089\/met.2008.0043","article-title":"Association between insulin resistance, glucose intolerance, and hypertension in pregnancy","volume":"7","author":"Negrato","year":"2009","journal-title":"Metab Syndr Relat Disord"},{"key":"10.1016\/j.fertnstert.2017.12.023_bib31","doi-asserted-by":"crossref","first-page":"548","DOI":"10.3109\/09513590.2015.1029447","article-title":"Metabolic profile of Diane-35 versus Diane-35 plus metformin in Chinese PCOS women under standardized life-style changes","volume":"31","author":"Wu","year":"2015","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.fertnstert.2017.12.023_bib32","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.maturitas.2015.06.030","article-title":"Oral contraception for women of middle age","volume":"82","author":"Ruan","year":"2015","journal-title":"Maturitas"},{"key":"10.1016\/j.fertnstert.2017.12.023_bib33","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1080\/13625187.2017.1317735","article-title":"Use of cyproterone acetate\/ethinylestradiol\u00a0in polycystic ovary syndrome: rationale and practical aspects","volume":"22","author":"Ruan","year":"2017","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.fertnstert.2017.12.023_bib34","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1159\/000341823","article-title":"Combined oral contraceptives in polycystic ovary syndrome\u2013indications and cautions","volume":"40","author":"Bozdag","year":"2013","journal-title":"Front Horm Res"},{"key":"10.1016\/j.fertnstert.2017.12.023_bib35","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1530\/JOE-14-0150","article-title":"Disorders of follicle development and steroidogenesis in ovaries of androgenised foetal sheep","volume":"225","author":"Comim","year":"2015","journal-title":"J Endocrinol"},{"key":"10.1016\/j.fertnstert.2017.12.023_bib36","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1093\/humrep\/dew325","article-title":"Effect of pretreatment with oral contraceptives and progestins on IVF outcomes in women with polycystic ovary syndrome","volume":"32","author":"Wei","year":"2017","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2017.12.023_bib37","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3109\/09513590.2014.974535","article-title":"Pregnancy complications in polycystic ovary syndrome patients","volume":"31","author":"Katulski","year":"2015","journal-title":"Gynecol Endocrinol"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028217321702?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028217321702?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T16:52:05Z","timestamp":1767113525000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028217321702"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["S0015028217321702"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2017.12.023","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparing the risk of adverse pregnancy outcomes of Chinese patients with polycystic ovary syndrome with and without antiandrogenic pretreatment","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2017.12.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a92017 American Society for Reproductive Medicine, Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}